{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:14:14Z","timestamp":1790140454165,"version":"4.0.1"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T00:00:00Z","timestamp":1624406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Autoimmune Autonomic Ganglionopathy (AAG) is an uncommon immune-mediated neurological disease that results in failure of autonomic function and is associated with autoantibodies directed against the ganglionic acetylcholine receptor (gnACHR). The antibodies are routinely detected by immunoprecipitation assays, such as radioimmunoassays (RIA), although these assays do not detect all patients with AAG and may yield false positive results. Autoantibodies against the gnACHR exert pathology by receptor modulation. Flow cytometric analysis is able to determine if this has occurred, in contrast to the assays in current use that rely on immunoprecipitation. Here, we describe the first high-throughput, non-radioactive flow cytometric assay to determine autoantibody mediated gnACHR immunomodulation. Previously identified gnACHR antibody seronegative and seropositive sera samples (RIA confirmed) were blinded and obtained from the Oxford Neuroimmunology group along with samples collected locally from patients with or without AAG. All samples were assessed for the ability to cause gnACHR immunomodulation utilizing the prototypical gnACHR expressing cell line, IMR-32. Decision limits were calculated from healthy controls, and Receiver Operating Characteristic (ROC) curves were constructed after unblinding all samples. One hundred and ninety serum samples were analyzed; all 182 expected negative samples (from healthy controls, autonomic disorders not thought to be AAG, other neurological disorders without autonomic dysfunction and patients with Systemic Lupus Erythematosus) were negative for immunomodulation (&amp;lt;18%), as were the RIA negative AAG and unconfirmed AAG samples. All RIA positive samples displayed significant immunomodulation. There were no false positive or negative samples. There was perfect qualitative concordance as compared to RIA, with an Area Under ROC of 1. Detection of Immunomodulation by flow cytometry for the identification of gnACHR autoantibodies offers excellent concordance with the gnACHR antibody RIA, and overcomes many of the shortcomings of immunoprecipitation assays by directly measuring the pathological effects of these autoantibodies at the cellular level. Further work is needed to determine the correlation between the degree of immunomodulation and disease severity.<\/jats:p>","DOI":"10.3389\/fimmu.2021.705292","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T06:58:56Z","timestamp":1624431536000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["A Flow Cytometric Assay to Detect Functional Ganglionic Acetylcholine Receptor Antibodies by Immunomodulation in Autoimmune Autonomic Ganglionopathy"],"prefix":"10.3389","volume":"12","author":[{"given":"Nicol\u00e1s","family":"Urriola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith M.","family":"Spies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Blazek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethan","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Adelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.9.1675","article-title":"Idiopathic Autonomic Neuropathy: Clinical, Neurophysiologic, and Follow-Up Studies on 27 Patients","volume":"44","author":"Suarez","year":"1994","journal-title":"Neurology"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.10333","article-title":"Autonomic Dysfunction in Peripheral Nerve Disease","volume":"27","author":"Low","year":"2003","journal-title":"Muscle Nerve"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200009213431204","article-title":"Autoantibodies to Ganglionic Acetylcholine Receptors in Autoimmune Autonomic Neuropathies","volume":"343","author":"Vernino","year":"2000","journal-title":"New Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1987.tb51321.x","article-title":"Clinical Correlations of Antibodies That Bind, Block, or Modulate Human Acetylcholine Receptors in Myasthenia Gravis","volume":"505","author":"Howard","year":"1987","journal-title":"Ann Ny Acad Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e0118312","DOI":"10.1371\/journal.pone.0118312","article-title":"Clinical Features of Autoimmune Autonomic Ganglionopathy and the Detection of Subunit-Specific Autoantibodies to the Ganglionic Acetylcholine Receptor in Japanese Patients","volume":"10","author":"Nakane","year":"2015","journal-title":"PloS One"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000263185.30294.61","article-title":"Autoimmune Autonomic Ganglionopathy: IgG Effects on Ganglionic Acetylcholine Receptor Current","volume":"68","author":"Wang","year":"2007","journal-title":"Neurology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2012.12.010","article-title":"Autoantibody-Induced Internalization of Nicotinic Acetylcholine Receptor \u03b13 Subunit Exogenously Expressed in Human Embryonic Kidney Cells","volume":"257","author":"Kobayashi","year":"2013","journal-title":"J Neuroimmunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2018.05.033","article-title":"Ganglionic Antibody Level as a Predictor of Severity of Autonomic Failure","volume":"93","author":"Cutsforth-Gregory","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2016.1226469","article-title":"Ganglionic Acetylcholine Receptor Autoantibodies in Patients With Autoimmune Diseases Including Primary Biliary Cirrhosis","volume":"27","author":"Maeda","year":"2016","journal-title":"Modern Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPYEOR6SGE8ZLU","article-title":"Detection of Acetylcholine Receptor Modulating Antibodies by Flow Cytometry","volume":"143","author":"Lozier","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26018","article-title":"Multimodal Biomarkers Quantify Recovery in Autoimmune Autonomic Ganglionopathy","volume":"89","author":"Koay","year":"2021","journal-title":"Ann Neurol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.118.5.563","article-title":"Functional Properties of Human Nicotinic AChRs Expressed by IMR-32 Neuroblastoma Cells Resemble Those of Alpha3beta4 AChRs Expressed in Permanently Transfected HEK Cells","volume":"118","author":"Nelson","year":"2001","journal-title":"J Gen Physiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/1745-6215-13-137","article-title":"Diagnostic Randomized Controlled Trials: The Final Frontier","volume":"13","author":"Rodger","year":"2012","journal-title":"Trials"},{"key":"B14","volume-title":"R: A Language and Environment for Statistical Computing","author":"Team","year":"2020"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the Tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J Open Source Softw"},{"key":"B16","volume-title":"Rocit: Performance Assessment of Binary Classifier With Visualization","author":"Khan","year":"2020"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e438","DOI":"10.1212\/NXI.0000000000000438","article-title":"Glycine Receptor Modulating Antibody Predicting Treatable Stiff-Person Spectrum Disorders","volume":"5","author":"Hinson","year":"2018","journal-title":"Neurol - Neuroimmunol Neuroinflamm"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.6.1806","article-title":"Neuronal Nicotinic ACh Receptor Antibody in Subacute Autonomic Neuropathy and Cancer-Related Syndromes","volume":"50","author":"Vernino","year":"1998","journal-title":"Neurology"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)68891-5","article-title":"Mapping of Surface Structures of Electrophorus Acetylcholine Receptor Using Monoclonal Antibodies","volume":"256","author":"Tzartos","year":"1981","journal-title":"J Biol Chem"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2008.03.017","article-title":"Characterization of Ganglionic Acetylcholine Receptor Autoantibodies","volume":"197","author":"Vernino","year":"2008","journal-title":"J Neuroimmunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.18-11-04166.1998","article-title":"Rapsyn Clusters Neuronal Acetylcholine Receptors But is Inessential for Formation of an Interneuronal Cholinergic Synapse","volume":"18","author":"Feng","year":"1998","journal-title":"J Neurosci"},{"key":"B22","article-title":"Definition of a Continuous Human Cell Line Derived From Neuroblastoma","volume":"30","author":"Tumilowicz","year":"1970","journal-title":"Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1996.66041454.x","article-title":"Characterization and Localization of Adrenal Nicotinic Acetylcholine Receptors: Evidence That Mab35-Nicotinic Receptors Are the Principal Receptors Mediating Adrenal Catecholamine Secretion","volume":"66","author":"Gu","year":"1996","journal-title":"J Neurochem"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2010.12.003","article-title":"Recombinant Expression of the AChR-Alpha1 Subunit for the Detection of Conformation-Dependent Epitopes in Myasthenia Gravis","volume":"21","author":"Ching","year":"2011","journal-title":"Neuromuscular Disord"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2009.78","article-title":"Ganglionic Acetylcholine Receptor Autoantibody: Oncological, Neurological, and Serological Accompaniments","volume":"66","author":"McKeon","year":"2009","journal-title":"Arch Neurol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006577","article-title":"Unintended Consequences of Mayo Paraneoplastic Evaluations","volume":"91","author":"Ebright","year":"2018","journal-title":"Neurology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/jnnp-2016-314758","article-title":"Intracellular and non-Neuronal Targets of Voltage-Gated Potassium Channel Complex Antibodies","volume":"88","author":"Lang","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/85520","article-title":"Auto-Antibodies to the Receptor Tyrosine Kinase MuSK in Patients With Myasthenia Gravis Without Acetylcholine Receptor Antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2013.270207","article-title":"Muscle-Specific Kinase (MuSK) Autoantibodies Suppress the MuSK Pathway and ACh Receptor Retention at the Mouse Neuromuscular Junction","volume":"592","author":"Ghazanfari","year":"2014","journal-title":"J Physiol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.705292\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T06:58:59Z","timestamp":1624431539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.705292\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,23]]},"references-count":29,"alternative-id":["10.3389\/fimmu.2021.705292"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.705292","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,23]]},"article-number":"705292"}}